Inventor · disambiguated record
David Heppner
Also filed as: HEPPNER DAVID · HEPPNER DAVID EARL
4 granted patents·10 pending applications·2 citations·filing 2016–2025
58Inventor score
Files withDANA FARBER CANCER INST INC12SCOTT DAVID A1THE UNIV OF VERMONT AND STATE AGRICULTURAL COLLEGE1
Top patents by PatentIndex Score
14 records- 0175US2025340534A1Allosteric egfr inhibitors and methods of use thereofDANA FARBER CANCER INST INC·Filed 2025·Application pending·0 cites
- 0275US2025340535A1Allosteric egfr inhibitors and methods of use thereofDANA FARBER CANCER INST INC·Filed 2025·Application pending·0 cites
- 0372US12391671B2Allosteric EGFR inhibitors and methods of use thereofDANA FARBER CANCER INST INC·Filed 2022·Granted Aug 19, 2025·0 cites·29 claims
- 0472US10143718B2Covalent inhibitors of dual oxidase 1 (DUOX 1)THE UNIV OF VERMONT AND STATE AGRICULTURAL COLLEGE·Filed 2016·Granted Dec 4, 2018·2 cites·20 claims
- 0560US2023406838A1Mutant selective egfr inhibitors and methods of use thereofDANA FARBER CANCER INST INC·Filed 2023·Application pending·0 cites
- 0649US12377080B2Allosteric EGFR inhibitors and methods of use thereofDANA FARBER CANCER INST INC·Filed 2020·Granted Aug 5, 2025·0 cites·20 claims
- 0748US2020377501A1Degraders of egfr and methods of use thereofDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 0846US2022233545A1Allosteric egfr inhibitors and methods of use thereofDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
- 0945US2023212171A1Allosteric egfr inhibitors and methods of use thereofSCOTT DAVID A·Filed 2021·Application pending·0 cites
- 1043US11584746B2Inhibitors of EGFR and methods of use thereofDANA FARBER CANCER INST INC·Filed 2019·Granted Feb 21, 2023·0 cites·22 claims
- 1142US2020375999A1Pharmaceutical combinations of egfr inhibitors and methods of use thereofDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 1242US2021077469A1Pharmaceutical combinations of egfr inhibitors and methods of use thereofDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 1341US2020390783A1Inhibitors of egfr and methods of use thereofDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 1441US2020377477A1Degraders of egfr and methods of use thereofDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Heppner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →